Cargando…
Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia
OBJECTIVE: To compare fertility-sparing therapies including oral progestogens, hysteroscopic resection (HR), and the levonorgestrel- releasing intrauterine system (LNG-IUS) in achieving disease regression, recurrence and live birth rate in well differentiate early-stage endometrial carcinoma (eEC) a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593673/ https://www.ncbi.nlm.nih.gov/pubmed/28915701 http://dx.doi.org/10.18632/oncotarget.17588 |
_version_ | 1783263087691825152 |
---|---|
author | Zhang, Qing Qi, Gonghua Kanis, Margaux J. Dong, Ruifen Cui, Baoxia Yang, Xingsheng Kong, Beihua |
author_facet | Zhang, Qing Qi, Gonghua Kanis, Margaux J. Dong, Ruifen Cui, Baoxia Yang, Xingsheng Kong, Beihua |
author_sort | Zhang, Qing |
collection | PubMed |
description | OBJECTIVE: To compare fertility-sparing therapies including oral progestogens, hysteroscopic resection (HR), and the levonorgestrel- releasing intrauterine system (LNG-IUS) in achieving disease regression, recurrence and live birth rate in well differentiate early-stage endometrial carcinoma (eEC) and complex atypical hyperplasia(CAH). STUDY DESIGN: This was a meta-analysis of previous studies focus on the fertility-sparing therapy for well differentiate early-stage endometrial carcinoma (eEC) and complex atypical hyperplasia (CAH). DATE SOURCES: Medline, the Cochrane Library and Embase was searched with the terms and Synonyms: words similar to eEC and CAH with therapies associated with fertility-sparing. MAIN OUTCOME MEASURES: The number of all patients accepted fertility sparing therapies, patients got regressed, relapsed and delivered were extracted from each study, and the regression, recurrence, and live birth rate of each study were calculated. The regression, recurrence and live birth rates between each two interventions were compared with the aid of meta-regression in packages of “meta” and ”meta for” written in R. RESULTS: Fifty-four studies reported fertility sparing therapies in young women with eEC and CAH were included. Meta-analysis showed that HR followed by progestogens achieved a higher pooled regression (98.06% vs 77.20% P < 0.0001) and live birth rate (52.57% vs 33.38%, P = 0.0944) and a lower recurrence rate compared with oral progestogens alone (4.79% vs 32.17% P = 0.0004). At the same time, the pooled live birth rate (52.57% vs 18.09% P =0.0399) of HR followed by progestogens are significantly higher than the LNG-IUS alone. Which no statistical difference in regression (98.06% vs 94.24%; P = 0.4098) and recurrence rates (4.79% vs 3.90% P = 0.8561) was seen. CONCLUSIONS: Of the available fertility-sparing therapeutic options, HR followed by progestogens may be a more effective one. |
format | Online Article Text |
id | pubmed-5593673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-55936732017-09-14 Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia Zhang, Qing Qi, Gonghua Kanis, Margaux J. Dong, Ruifen Cui, Baoxia Yang, Xingsheng Kong, Beihua Oncotarget Review OBJECTIVE: To compare fertility-sparing therapies including oral progestogens, hysteroscopic resection (HR), and the levonorgestrel- releasing intrauterine system (LNG-IUS) in achieving disease regression, recurrence and live birth rate in well differentiate early-stage endometrial carcinoma (eEC) and complex atypical hyperplasia(CAH). STUDY DESIGN: This was a meta-analysis of previous studies focus on the fertility-sparing therapy for well differentiate early-stage endometrial carcinoma (eEC) and complex atypical hyperplasia (CAH). DATE SOURCES: Medline, the Cochrane Library and Embase was searched with the terms and Synonyms: words similar to eEC and CAH with therapies associated with fertility-sparing. MAIN OUTCOME MEASURES: The number of all patients accepted fertility sparing therapies, patients got regressed, relapsed and delivered were extracted from each study, and the regression, recurrence, and live birth rate of each study were calculated. The regression, recurrence and live birth rates between each two interventions were compared with the aid of meta-regression in packages of “meta” and ”meta for” written in R. RESULTS: Fifty-four studies reported fertility sparing therapies in young women with eEC and CAH were included. Meta-analysis showed that HR followed by progestogens achieved a higher pooled regression (98.06% vs 77.20% P < 0.0001) and live birth rate (52.57% vs 33.38%, P = 0.0944) and a lower recurrence rate compared with oral progestogens alone (4.79% vs 32.17% P = 0.0004). At the same time, the pooled live birth rate (52.57% vs 18.09% P =0.0399) of HR followed by progestogens are significantly higher than the LNG-IUS alone. Which no statistical difference in regression (98.06% vs 94.24%; P = 0.4098) and recurrence rates (4.79% vs 3.90% P = 0.8561) was seen. CONCLUSIONS: Of the available fertility-sparing therapeutic options, HR followed by progestogens may be a more effective one. Impact Journals LLC 2017-05-03 /pmc/articles/PMC5593673/ /pubmed/28915701 http://dx.doi.org/10.18632/oncotarget.17588 Text en Copyright: © 2017 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Review Zhang, Qing Qi, Gonghua Kanis, Margaux J. Dong, Ruifen Cui, Baoxia Yang, Xingsheng Kong, Beihua Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia |
title | Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia |
title_full | Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia |
title_fullStr | Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia |
title_full_unstemmed | Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia |
title_short | Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia |
title_sort | comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593673/ https://www.ncbi.nlm.nih.gov/pubmed/28915701 http://dx.doi.org/10.18632/oncotarget.17588 |
work_keys_str_mv | AT zhangqing comparisonamongfertilitysparingtherapiesforwelldifferentiatedearlystageendometrialcarcinomaandcomplexatypicalhyperplasia AT qigonghua comparisonamongfertilitysparingtherapiesforwelldifferentiatedearlystageendometrialcarcinomaandcomplexatypicalhyperplasia AT kanismargauxj comparisonamongfertilitysparingtherapiesforwelldifferentiatedearlystageendometrialcarcinomaandcomplexatypicalhyperplasia AT dongruifen comparisonamongfertilitysparingtherapiesforwelldifferentiatedearlystageendometrialcarcinomaandcomplexatypicalhyperplasia AT cuibaoxia comparisonamongfertilitysparingtherapiesforwelldifferentiatedearlystageendometrialcarcinomaandcomplexatypicalhyperplasia AT yangxingsheng comparisonamongfertilitysparingtherapiesforwelldifferentiatedearlystageendometrialcarcinomaandcomplexatypicalhyperplasia AT kongbeihua comparisonamongfertilitysparingtherapiesforwelldifferentiatedearlystageendometrialcarcinomaandcomplexatypicalhyperplasia |